Login

Eli Lilly picks Virginia for $5 billion manufacturing plant

Global drugmaker's Richmond project is part of $50 billion plan to increase domestic production
Eli Lilly opened a pharmaceutical manufacturing site in Concord, North Carolina, last year, pictured. (CoStar)
Eli Lilly opened a pharmaceutical manufacturing site in Concord, North Carolina, last year, pictured. (CoStar)
CoStar Analytics
September 16, 2025 | 9:43 P.M.

Pharmaceutical giant Eli Lilly and Co. has selected Virginia for the site of a $5 billion manufacturing plant, the first of four new U.S. development sites it plans to announce as it looks to invest $50 billion to ramp up its domestic medicine production.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE


  • Properties
News | Eli Lilly picks Virginia for $5 billion manufacturing plant